Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28
- PMID: 12393799
- DOI: 10.1093/hmg/11.23.2877
Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28
Abstract
We ascertained a large American family with an autosomal dominant form of progressive non-syndromic sensorineural hearing loss. After excluding linkage to known deafness loci, we performed a genome-wide scan and found linkage to marker GAAT1A4 on chromosome 8q22 (LOD=5.12 at theta=0), and this locus was designated DFNA28. Sequencing of six candidate genes in the 1.4 cM linked region identified a frameshift mutation (1609-1610insC) resulting in a premature translation stop codon in exon 14 of the gene TFCP2L3 (transcription factor cellular promoter 2-like 3). TFCP2L3 is a member of a family of transcription factor genes whose archetype is TFCP2, a mammalian homolog of the Drosophila gene grainyhead. Northern blot analyses and in situ hybridization studies show that mouse Tfcp2l3 is expressed in many epithelial tissues, including cells lining the cochlear duct, at embryonic day 18.5 and postnatal day 5.
Similar articles
-
Confirmation of GRHL2 as the gene for the DFNA28 locus.Am J Med Genet A. 2013 Aug;161A(8):2060-5. doi: 10.1002/ajmg.a.36017. Epub 2013 Jun 27. Am J Med Genet A. 2013. PMID: 23813623 Free PMC article.
-
Evaluation of the contribution of the EYA4 and GRHL2 genes in Korean patients with autosomal dominant non-syndromic hearing loss.PLoS One. 2015 Mar 17;10(3):e0119443. doi: 10.1371/journal.pone.0119443. eCollection 2015. PLoS One. 2015. PMID: 25781927 Free PMC article.
-
Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24.J Am Soc Nephrol. 2003 Jul;14(7):1794-803. doi: 10.1097/01.asn.0000071513.73427.97. J Am Soc Nephrol. 2003. PMID: 12819239
-
Non-syndromic autosomal dominant sensorineural hearing loss: a new field of research.Clin Otolaryngol Allied Sci. 1998 Feb;23(1):9-17. doi: 10.1046/j.1365-2273.1998.00093.x. Clin Otolaryngol Allied Sci. 1998. PMID: 9563659 Review. No abstract available.
-
Characterization of autosomal dominant non-syndromic hearing loss loci: DFNA 4, 6, 10 and 13.Adv Otorhinolaryngol. 2000;56:84-96. doi: 10.1159/000059085. Adv Otorhinolaryngol. 2000. PMID: 10868218 Review. No abstract available.
Cited by
-
Genetic Hearing Loss and Gene Therapy.Genomics Inform. 2018 Dec;16(4):e20. doi: 10.5808/GI.2018.16.4.e20. Epub 2018 Dec 28. Genomics Inform. 2018. PMID: 30602081 Free PMC article.
-
Genetics of Nonsyndromic Congenital Hearing Loss.Scientifica (Cairo). 2016;2016:7576064. doi: 10.1155/2016/7576064. Epub 2016 Feb 18. Scientifica (Cairo). 2016. PMID: 26989561 Free PMC article. Review.
-
Genetics of vestibular disorders: pathophysiological insights.J Neurol. 2016 Apr;263 Suppl 1:S45-53. doi: 10.1007/s00415-015-7988-9. Epub 2016 Apr 15. J Neurol. 2016. PMID: 27083884 Free PMC article. Review.
-
Gene therapy development in hearing research in China.Gene Ther. 2020 Aug;27(7-8):349-359. doi: 10.1038/s41434-020-0177-1. Epub 2020 Jul 17. Gene Ther. 2020. PMID: 32681137 Review.
-
GRHL2 and AP2a coordinate early surface ectoderm lineage commitment during development.iScience. 2023 Feb 3;26(3):106125. doi: 10.1016/j.isci.2023.106125. eCollection 2023 Mar 17. iScience. 2023. PMID: 36843855 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials